🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the test product Budesonide/formote...
Status
Completed
Location
Orion Pharma Phase I Unit
Start Date
2011-07
Trial ID
NCT01386996
Treatments Being Tested
The primary objective is to compare the efficacy of Symbicort Single inhale...
Status
Completed
Location
Research Site
Start Date
2005-12
Trial ID
NCT00628758
Treatments Being Tested
Computational Fluid Dynamics (CFD) is a new functional imaging method. Sinc...
Status
Completed
Location
University Hospital Antwerp
Start Date
2010-06
Trial ID
NCT01329276
Treatments Being Tested
The purpose of this study is to compare the test product Budesonide/formote...
Status
Completed
Location
Orion Pharma Clinical Pharmacology Unit
Start Date
2012-05
Trial ID
NCT01593826
Due to the complexity of orally inhaled products (combination of a formulat...
Status
Completed
Location
Phase I Unit, Orion Pharma
Start Date
2010-08
Trial ID
NCT01181063
Treatments Being Tested
To assess if Symbicort forte Turbuhaler (during two weeks) is as effective ...
Status
Completed
Location
Research Site
Start Date
2005-09
Trial ID
NCT00259779
Treatments Being Tested
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
The purpose of this study is to compare the test product Budesonide/formote...
Status
Completed
Location
PAREXEL International GmbH
Start Date
2012-06
Trial ID
NCT01627158
This non-interventional study is to analyse the therapeutic effectiveness i...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00837629
The aim of the study is to assess and compare the Pharmacokinetic (PK) of B...
Status
Completed
Location
Parexel International GmbH
Start Date
2011-10
Trial ID
NCT01457716
Treatments Being Tested